Ricerca's Lyon facility obtains ISO 9001:2008 certification

Ricerca Biosciences, a uniquely integrated preclinical contract research drug development company providing services to the pharmaceutical industry, is pleased to announce that its Ricerca France, Lyon facility, has recently obtained the ISO 9001:2008 certification for all activities performed at the site.

“As a recipient of this certification, our concern and thorough attention to our client needs are evident. Ensuring our discovery and development services meet the standards required of us and those we guarantee to our clients enables Ricerca to continue to be the trusted CRO in this industry”

In addition, Ricerca Taiwan, Taipei facility, also successfully passed the ISO 9001:2008 certification in October 2009.

International Organization for Standardization (ISO) is the world's largest developer and publisher of international standards. It is a non-governmental organization that forms a bridge between public and private sectors, enabling a consensus to be reached on solutions that meet both the requirements of business and the broader needs of society.

The ISO 9000 family, including the ISO 9001, addresses the requirements for implementing an efficient quality management system. This standard ensures that the organization fulfills and achieves continual improvement of its performance in pursuit of the customer's requirements, applicable regulatory requirements and enhancement of customer satisfaction.

"As a recipient of this certification, our concern and thorough attention to our client needs are evident. Ensuring our discovery and development services meet the standards required of us and those we guarantee to our clients enables Ricerca to continue to be the trusted CRO in this industry," stated Chairman and CEO of Ricerca, Ian Lennox.

Ricerca offers a unique spectrum of services for the areas of agrochemical registration, environmental analysis and pre-investigational new drug (IND) biopharmaceutical registration.

SOURCE Ricerca Biosciences